Remission and Joint Damage Progression in Early Rheumatoid Arthritis
Public ClinicalTrials.gov record NCT00122382. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIIB Multi-center, Randomized, Double-Blind Study to Evaluate Remission and Joint Damage Progression in Methotrexate Naive Early Erosive RA Subjects Treated With Abatacept Plus Methotrexate Compared With Methotrexate
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a world wide study to evaluate the remission and joint damage in subjects treated with abatacept in addition to methotrexate versus subjects who receive methotrexate along with a placebo.
Study identification
- NCT ID
- NCT00122382
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,052 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2005 (Type not available)
- Primary completion
- Feb 2008 (Actual)
- Completion
- Feb 2009 (Actual)
- Last update posted
- Nov 16, 2010
2005 – 2009
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rheumatology Associates Of North Alabama | Huntsville | Alabama | 35801 | — |
| Talbert Medical Group | Huntington Beach | California | 92646 | — |
| Arthritis Assoc And Osteo Ctr Of Col Sprgs | Colorado Springs | Colorado | 80910 | — |
| New England Research Associates, Llc | Trumbull | Connecticut | 06611 | — |
| Diagnostic Rheumatology And Research | Indianapolis | Indiana | 46227 | — |
| Osteoporosis And Clinical Trials Center | Cumberland | Maryland | 21502 | — |
| Malamet & Klein, Md, Pa | Hagerstown | Maryland | 21740 | — |
| Arthritis Center Of Nebraska | Lincoln | Nebraska | 68516 | — |
| Regional Rheumatology Associates | Binghamton | New York | 13905 | — |
| Carolina Bone & Joint | Charlotte | North Carolina | 28210 | — |
| Physicians East, Pa | Greenville | North Carolina | 27834 | — |
| Carolina Pharmaceutical Research | Statesville | North Carolina | 28625 | — |
| Lion Research | Norman | Oklahoma | 73071 | — |
| Health Research Of Oklahoma | Oklahoma City | Oklahoma | 73103 | — |
| Lynn Health Sciences Institute | Oklahoma City | Oklahoma | 73112 | — |
| Altoona Center For Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Low Country Research Center | Charleston | South Carolina | 29406 | — |
| Walter F Chase Md Pa | Austin | Texas | 78705 | — |
| Arthritis Clinic Of Northern Virginia, P.C. | Arlington | Virginia | 22205 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00122382, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 16, 2010 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00122382 live on ClinicalTrials.gov.